ArticleAmerican journal of industrial medicine2016
Respirable indium exposures, plasma indium, and respiratory health among indium-tin oxide (ITO) workers.
Article in American journal of industrial medicine, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
22 citing papers in PubMed, 59 citations in OpenAlex.
- Indium (III) chloride inhibits testicular Leydig cell proliferation by disrupting centrosome copy numbers.Molecular medicine reports · 2026Article
- Key Molecular Cascade in Indium Tin Oxide Nanoparticle-Induced Pulmonary Fibrosis.Environment & health (Washington, D.C.) · 2025Article
- Investigating the Local Bonding Structure of Amorphous Zinc Tin Oxide to Elucidate the Effect of Altering the Intercation Ratio.The journal of physical chemistry. C, Nanomaterials and interfaces · 2024Article
- Variation in the Bandgap of Amorphous Zinc Tin Oxide: Investigating the Thickness DependenceACS omega · 2024Article
- Conversion of the bronchial tree into a conforming electrode to ablate the lung nodule in a porcine model.Communications medicine · 2023Article
- Pulmonary effects of exposure to indium and its compounds: cross-sectional survey of exposed workers and experimental findings in rodents.Particle and fibre toxicology · 2022Article
- Two-year follow-up of exposure, engineering controls, respiratory protection and respiratory health among workers at an indium-tin oxide (ITO) production and reclamation facility.Occupational and environmental medicine · 2022Article
- Elevated COAntioxidants (Basel, Switzerland) · 2022Article
- COFrontiers in plant science · 2022Article
- Pulmonary and Systemic Toxicity in a Rat Model of Pulmonary Alveolar Proteinosis Induced by Indium-Tin Oxide Nanoparticles.International journal of nanomedicine · 2022Article
- Assessment of Occupational Exposure to Indium Dust for Indium-Tin-Oxide Manufacturing Workers.Biomolecules · 2021Article
- Low serum indium levels induce expression disorders of some inflammatory factors.International archives of occupational and environmental health · 2021Article
- Biomonitorization of concentrations of 28 elements in serum and urine among workers exposed to indium compounds.PloS one · 2021Article
- Work Tasks as Determinants of Respirable and Inhalable Indium Exposure among Workers at an Indium-Tin Oxide Production and Reclamation Facility.Annals of work exposures and health · 2020Article
- Article
- Evaluation of personal exposure of workers to indium concentrations in total dust and its respirable fraction at three Japanese indium plants.Industrial health · 2019Article
- Article
- A field evaluation of a single sampler for respirable and inhalable indium and dust measurements at an indium-tin oxide manufacturing facility.Journal of occupational and environmental hygiene · 2019Article
- NIOSH's Respiratory Health Division: 50 years of science and service.Archives of environmental & occupational health · 2019Article
- Quantitative assessment of occupational exposure to total indium dust in Japanese indium plants.Industrial health · 2018Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors at 4 institutions in 2 countries.
Funding
Abstract
backgroundWorkers manufacturing indium-tin oxide (ITO) are at risk of elevated indium concentration in blood and indium lung disease, but relationships between respirable indium exposures and biomarkers of exposure and disease are unknown.
methodsFor 87 (93%) current ITO workers, we determined correlations between respirable and plasma indium and evaluated associations between exposures and health outcomes.
resultsCurrent respirable indium exposure ranged from 0.4 to 108 μg/m(3) and cumulative respirable indium exposure from 0.4 to 923 μg-yr/m(3) . Plasma indium better correlated with cumulative (rs = 0.77) than current exposure (rs = 0.54) overall and with tenure ≥1.9 years. Higher cumulative respirable indium exposures were associated with more dyspnea, lower spirometric parameters, and higher serum biomarkers of lung disease (KL-6 and SP-D), with significant effects starting at 22 μg-yr/m(3) , reached by 46% of participants.
conclusionsPlasma indium concentration reflected cumulative respirable indium exposure, which was associated with clinical, functional, and serum biomarkers of lung disease. Am. J. Ind. Med. 59:522-531, 2016. Published 2016. This article is a U.S. Government work and is in the public domain in the USA.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.